2013印度全球疫苗高峰會(huì)（3月5-7日 印度.浦那）

Dr Suresh Jadhav, Executive Director, Serum Institute, India

Dr Rajiv Indravadan Modi,Director/Managing Director, Cadila Pharmaceuticals, India

Dr Inderjit Singh Sarao, Associate Director, Merck, USA

Dr James F. Young, Chairman, Novavax, USA

Dr Harish Iyer, CEO, Shantha Biotechnics, India

Dr Norman Baylor, Advisor, PATH MVI Vaccine Science Portfolio Advisory Council (VSPAC), USA

Dr Ranga Iyer, Advisor, Indian Health Progress & Global Pharma Associations, India

Dr Raj Shankar Ghosh, Technical Director, PATH , India

Dr Stanley Erck, President and CEO, Novavax, USA

Dr Anand Kumar, Deputy Managing Director, Indian Immunologicals, India

Dr V. Krishna Mohan, Executive Director, Bharat Biotech International, India

Dr SD Ravetkar, Executive Director, Serum Institute, India

Dr Reinhard Glueck, Chief Scientific Officer, Zydus Cadila, India

Dr Shirshendu Mukherjee, Senior Strategic Advisor, Wellcome Trust, India

Dr Davinder Gill, Chief Executive Officer, MSD Wellcome Trust Hilleman Laboratories, India

Dr Ramesh S. Paranjape, Director, National AIDS Research Institute, India

Dr Vipin Vashishtha, Convener, Indian Academy of Pediatrics - Committee on Immunization, India

Helen Yang, Business Development Director, Sinovac Biotech, China

Dr Sanjay Singh, Chairman, Gennova Biopharma, India

Dr Jacqui Shea, General Manager, Oxford-Emergent Tuberculosis Consortium, UK

Abdul Muktadir, Managing Director, Incepta, Bangladesh

Dr Rajendra Jani, Senior Vice President of Clinical R&D, Cadila Healthcare, India

Dr Gregory Glenn, Senior VP and CMO, Novovax

Dr Ashish Bavdekar, President, IAP - Gastroenterology Chapter

Ashish Kenneth Kelley, Co-Founder, CEO, Executive Chairman, PaxVax

Prof T Jacob John, Virologist, Christian Medical College in Vellore, WHO Committee Global Polio Eradication, India

Dr Shailesh Mehta, Medical Director of Clinical R&D (Medical Affairs Biologics - South Asia),GSK

Dr Ramesh Matur, General Manager of R&D, Indian Immunologicals

Dr Sudhakar Konda, Vice President, One Stream R&D (Panacea)

Dr Steve Whitehead, Head of Dengue Project, Laboratory of Infectious Diseases of NIH

Dr Subhra Chakrabarti, Head of Manufacturing Technology, Shantha Biotechnics

Dr Rakesh Sinha, General Manager and Project Director of JE Vaccine, Biological E.

Dr Nathelie Garcon, Vice President and Head of Global Adjuvant Centre for Vaccine Development,GSK Biologicals

Dr Anuj Walia, Regional Director of Medical Affairs, MSD Pharmaceuticals

Dr Alfred Luitjens, Early Stage Development Leader for the Inactivated Polio Project and Senior Scientist, Crucell